Advertisement
UCB Announces Commercial Availability Of Zilbrysq In U.S. To Treat Generalized Myasthenia Gravis
(RTTNews) - Biopharmaceutical company UCB announced Wednesday that ZILBRYSQ (zilucoplan) is now available in the U.S. for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
ZILBRYSQ was approved by the U.S. Food and Drug Administration (FDA) on October 17, 2023.
ZILBRYSQ is available by prescription as a ready-to-use pre-filled syringe that is a once-daily administration. Healthcare providers who prescribe ZILBRYSQ must enroll in the ZILBRYSQ REMS because of the risk of serious meningococcal infections.
Myasthenia gravis is a rare, chronic, autoimmune neuromuscular disease, which is characterized by muscle weakness that worsens after periods of activity and improves after periods of rest.
read more
UCB Announces U.S. Availability Of BIMZELX To Treat Adults With Moderate-to-Severe Plaque Psoriasis
Biopharmaceutical company UCB (UCB) announced Tuesday the commercial availability of BIMZELX in the United States for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
RTTNews
|
624 dagar sedan
U.S. Pending Home Sales Unexpectedly Decrease In June
Pending home sales in the U.S. unexpectedly decreased in the month of June, according to a report released by the National Association of Realtors on Wednesday. NAR said its pending home sales index slid by 0.8 percent to 72.0 in June after jumping by 1.8 percent to 72.6 in May. Economists had expected pending home sales to rise by 0.2 percent.
RTTNews
|
1h 28minuter sedan
Bank Of Canada Leaves Interest Rates Unchanged For Third Straight Meeting
In a widely expected move, the Bank of Canada on Wednesday announced that it has once again decided to leave interest rates unchanged. The Bank of Canada said it decided to maintain its target for the overnight rate at 2.75 percent, with the Bank Rate at 3 percent and the deposit rate at 2.70 percent.
RTTNews
|
2h 12minuter sedan
U.S. GDP Rebounds In Q2 Amid Sharp Pullback By Imports
The Commerce Department released a report on Wednesday showing the U.S. economy rebounded by more than expected in the second quarter of 2025. The report said real gross domestic product surged by 3.0 percent in the second quarter after falling by 0.5 percent in the first quarter. Economists had expected GDP to jump by 2.5 percent.
RTTNews
|
2h 22minuter sedan
U.S. Private Sector Job Growth Exceeds Estimates In July
Payroll processor ADP released a report on Wednesday showing private sector employment in the U.S. increased by more than expected in the month of July. The report said private sector employment jumped by 104,000 jobs in July after slipping by a revised 23,000 jobs in June.
RTTNews
|
2h 37minuter sedan
Eurozone Economy Fares Better Than Expected In Q2
The euro area economy logged better-than-expected growth in the second quarter but the pace of expansion slowed markedly as the first quarter performance was inflated after U.S. importers frontloaded their orders to reduce the cost burden of higher tariffs. Gross domestic product grew 0.1 percent sequentially, after rising 0.6 percent in the first quarter, preliminary flash estimate from Eurostat.
RTTNews
|
3h 10minuter sedan
U.S. Gross Domestic Product Rebounds More Than Expected In Q2
The Commerce Department released a report on Wednesday showing the U.S. economy rebounded by more than expected in the second quarter of 2025.
RTTNews
|
3h 49minuter sedan
Bay Street Likely To Open On Mixed Note; BoC, Fed Policy Announcement In Focus
Somewhat subdued U.S. and Canadian futures, and mixed commodity prices point to a mixed start for Canadian stocks on Wednesday. The focus will be on the monetary policy announcements from the Bank of Canada and the Federal Reserve.
RTTNews
|
3h 55minuter sedan
